FIELD: medicine, pharmaceutical industry. SUBSTANCE: new disclosed rectal suppositories contain interferon α2, tocopherol and vitamin C in certain ratios of components. Suppositories are introduced with the aid of a special single-use device comprising a hollow cylinder, a piston with rod and a removable member. The device is hygienic and convenient both for the patient and medical personnel. EFFECT: higher immunomodulating and antivirus activity, elimination of complications associated with parenteral and enteral introduction of preparation. 2 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| METHOD OF TREATMENT OF CHILDREN WITH ACUTE RESPIRATORY VIRAL INFECTIONS | 2000 |
|
RU2170587C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| METHOD FOR TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN SUFFERING FROM ACUTE RESPIRATORY VIRAL INFECTION (ARVI) OFTEN AND/OR FOR A LONG TIME | 2001 |
|
RU2271828C2 |
| OINTMENT | 1995 |
|
RU2114611C1 |
